Metformin has been reported to improve glucose tolerance, ameliorate insulin resistance, and reduce obesity by increasing TUDCA levels, while GUDCA has also been shown to improve insulin sensitivity in diabetic populations [9, 34]. This evidence concerns the gene INS and obesity disorder.